1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- Author
-
Craig French, Daniel De Backer, Waleed Alhazzani, Ruth M. Kleinpell, Mitchell M. Levy, Dilip R. Karnad, B. Taylor Thompson, Marco Ranieri, Christopher W. Seymour, Lisa Shieh, Khalid A. Shukri, Anand Kumar, Lauralyn McIntyre, Alan E. Jones, Gordon D. Rubenfeld, Janice L. Zimmerman, Craig M. Coopersmith, Jean Louis Vincent, John E. Mazuski, Tiffany M. Osborn, Sean R. Townsend, Derek C. Angus, Steven Q. Simpson, Paolo Navalesi, Thiago Lisboa, John Myburgh, Gordon R. Bernard, Bram Rochwerg, Sangeeta Mehta, Herwig Gerlach, Charles L. Sprung, John J. Marini, Ricard Ferrer, W. Joost Wiersinga, Thomas Van der Poll, Laura Evans, Christa A. Schorr, Anthony S. McLean, Seitaro Fujishima, Flávia Ribeiro Machado, Steven M. Hollenberg, Maureen A. Seckel, Geoffrey J. Bellinghan, Colleen M. Plunkett, Osamu Nishida, John C. Marshall, Jean Daniel Chiche, Jorge Hidalgo, Andrew Rhodes, Richard Beale, Djillali Annane, Jonathan E. Sevransky, Rui Moreno, Mark E. Nunnally, Anders Perner, R. Phillip Dellinger, Mervyn Singer, Younsuck Koh, Massimo Antonelli, AII - Infectious diseases, Infectious diseases, Center of Experimental and Molecular Medicine, AII - Amsterdam institute for Infection and Immunity, Rhodes, A., Evans, L.E., Alhazzani, W., Levy, M.M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J.E., Sprung, C.L., Nunnally, M.E., Rochwerg, B., Rubenfeld, G.D., Angus, D.C., Annane, D., Beale, R.J., Bellinghan, G.J., Bernard, G.R., Chiche, J.-D., Coopersmith, C., De Backer, D.P., French, C.J., Fujishima, S., Gerlach, H., Hidalgo, J.L., Hollenberg, S.M., Jones, A.E., Karnad, D.R., Kleinpell, R.M., Koh, Y., Lisboa, T.C., Machado, F.R., Marini, J.J., Marshall, J.C., Mazuski, J.E., McIntyre, L.A., McLean, A.S., Mehta, S., Moreno, R.P., Myburgh, J., Navalesi, P., Nishida, O., Osborn, T.M., Perner, A., Plunkett, C.M., Ranieri, M., Schorr, C.A., Seckel, M.A., Seymour, C.W., Shieh, L., Shukri, K.A., Simpson, S.Q., Singer, M., Thompson, B.T., Townsend, S.R., Van der Poll, T., Vincent, J.-L., Wiersinga, W.J., Zimmerman, J.L., Dellinger, R.P., MacHado, F.R., and Van Der Poll, T.
- Subjects
Shock, Septic, Anti-Bacterial Agent ,vancomycin ,fluid resuscitation ,high risk patient ,Critical Care and Intensive Care Medicine ,anticoagulant agent ,intensive care unit ,capillary blood ,Septic shock ,Medicine ,pulmonary artery catheter ,health care organization ,Nutritional Support ,beta 2 adrenergic receptor stimulating agent ,critical illne ,clinical trial ,Shock, Septic ,Renal Replacement Therapy ,Grading of Recommendations Assessment, Development, and Evaluation criteria ,priority journal ,risk factor ,health care quality ,nutritional assessment ,health care policy ,drug withdrawal ,standards, Anti-Bacterial Agent ,pyelonephriti ,survival rate ,medicine.medical_specialty ,Evidence-based medicine ,Sepsis bundle ,Sepsi ,Critical Illness ,Best practice ,fresh frozen plasma ,bicarbonate ,Development ,piperacillin plus tazobactam ,Article ,03 medical and health sciences ,ertapenem ,critically ill patient ,hemodynamic ,vascular access device ,Sepsis ,neuromuscular blocking agent ,Guidelines ,Infection ,Sepsis bundles ,Sepsis syndrome ,Surviving Sepsis Campaign ,cefepime ,mycosi ,neutropenia ,hydrocortisone ,education ,insulin treatment ,levofloxacin ,point of care testing ,anticoagulant therapy ,meta analysi ,funding ,screening ,dobutamine ,respiratory failure ,infection prevention ,noninvasive ventilation ,treatment response ,Guideline ,thrombomodulin ,glucose blood level ,Vasoconstrictor Agent ,Blood Glucose ,evidence based medicine ,thrombosis prevention ,histamine H2 receptor antagonist ,virus infection ,Vasoconstrictor Agents ,intensive care ,artificial ventilation ,adult respiratory distress syndrome ,Development and Evaluation criteria ,infection control ,assessment of human ,stress ulcer ,sedation ,purification ,Critical Care ,noradrenalin ,cohort analysi ,MEDLINE ,doripenem ,parenteral nutrition ,carbapenem ,high frequency ventilation ,blood ,epinephrine ,pharmacokinetic parameter ,hypertensive agent ,supine position ,business.industry ,fluid balance ,penicillin derivative ,Nutrition Assessment ,antiinfective agent, abdominal infection ,patient care planning ,resuscitation ,Review ,0302 clinical medicine ,meropenem ,prokinetic agent ,consensu ,antibiotic therapy ,antibiotic agent ,colistin ,education.field_of_study ,low molecular weight heparin ,creatinine ,consensus development ,pulmonary artery catheterization ,hypertensive factor ,anemia ,and Evaluation criteria ,antiinfective agent ,antithrombin ,erythropoietin ,dopamine ,Human ,insulin ,corticosteroid ,teleconference ,erythrocyte transfusion ,proton pump inhibitor ,drug combination ,omega 3 fatty acid ,gastrointestinal hemorrhage ,cilastatin plus imipenem ,fluid therapy ,Settore MED/41 - ANESTESIOLOGIA ,unindexed drug ,Humans ,bacteremia ,lactic acidemia ,Intensive care medicine ,hypoxemia ,treatment duration ,practice guideline ,cephalosporin derivative ,medicine.disease ,mortality ,Respiration, Artificial ,ceftriaxone ,immunoglobulin ,vasopressin ,artery catheter ,heparin ,Grading of Recommendations Assessment ,low drug dose ,calcitonin ,030212 general & internal medicine ,randomized controlled trial (topic) ,glucose ,pharmacokinetic ,electronic medical record ,teicoplanin ,evidence based practice ,analgesia ,analgesic agent ,drotrecogin ,Anti-Bacterial Agents ,Intensive Care Units ,drug contraindication ,positive end expiratory pressure ,bronchospasm ,DOPA ,blood sampling ,oliguria ,procalcitonin ,heart muscle ischemia ,thrombocyte transfusion ,conflict of interest ,Population ,venous thromboembolism ,vascular acce ,dalteparin ,ciprofloxacin ,acute kidney failure ,renal protection ,030208 emergency & critical care medicine ,vasoconstrictor agent, acute kidney failure ,immune deficiency ,bleeding ,pharmacodynamic ,crystalloid ,hemoglobin determination ,business ,Grading of Recommendations Assessment Development and Evaluation system ,arterial blood - Abstract
Objective: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012." Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development. Methods: The panel consisted of five sections: hemodynamics infection adjunctive therapies metabolic and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable. Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions. Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality. © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
- Published
- 2017